NDC codes

FDA NDC Directory
Product NDC (as listed)0023-6118Labeler and product segments. Claims need a package NDC.
Product NDC at billing width00023-6118Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
0023-6118-03000236118033.5 g in 1 TUBE, WITH APPLICATOR (0023-6118-03)Marketed from Mar 13, 1997

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Condylox
Generic name (nonproprietary)
podofilox
Active ingredients
Podofilox — 5 mg/g
Dosage form
Gel
Route
Topical
Labeler
Allergan, Inc.NDC labeler code 0023
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 020529
Marketing start
Marketing end
Other FDA classes
Decreased Mitosis (Physiologic effect)
Identifiers
Product ID 0023-6118_9f2892be-8330-4fd1-930e-b4d204df4e03SPL ID 9f2892be-8330-4fd1-930e-b4d204df4e03SPL set ID 032e4bcb-b1ed-4029-b2a6-e92f3bf5cc37RxCUI 312466, 351750UNII L36H50F353UPC 0300236118037

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400023611803 followed by a unit qualifier and the quantity

Package 00023-6118-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS AND USAGE Condylox Gel 0.5% is indicated for the topical treatment of anogenital warts (external genital warts and perianal warts). This product is not indicated in the treatment of mucous membrane warts (see PRECAUTIONS ). Diagnosis Although anogenital warts have a characteristic appearance, histopathologic confirmation should be obtained if there is any doubt of the diagnosis. Differentiating warts from squamous cell carcinoma and "Bowenoid papulosis" is of particular concern. Squamous cell carcinoma may also be associated with human papillomavirus which should not be treated with Condylox Gel 0.5%.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0023-6118

What is NDC 0023-6118?
0023-6118 is the product NDC for Condylox (podofilox), Podofilox 5 mg/g gel, listed with the FDA by Allergan, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Condylox (Podofilox).
What is the active ingredient?
Podofilox.
Who is the labeler?
Allergan, Inc., NDC labeler code 0023. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Condylox?
None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in